| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| 1 | AN ACT concerning State government.
| |||||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||
| 3 | represented in the General Assembly:
| |||||||||||||||||||||
| 4 | Section 5. The Substance Use Disorder Act is amended by | |||||||||||||||||||||
| 5 | changing Section 15-10 and by adding Section 5-26 as follows: | |||||||||||||||||||||
| 6 | (20 ILCS 301/5-26 new) | |||||||||||||||||||||
| 7 | Sec. 5-26. OPS harm reduction services. | |||||||||||||||||||||
| 8 | (a) Legislative findings. The General Assembly finds the | |||||||||||||||||||||
| 9 | following: | |||||||||||||||||||||
| 10 | (1) Illinois is experiencing a growing overdose | |||||||||||||||||||||
| 11 | crisis. According to the Centers for Disease Control and | |||||||||||||||||||||
| 12 | Prevention, over 4,000 Illinoisans died from overdoses | |||||||||||||||||||||
| 13 | between January 2021 and January 2022, a 12.6% increase | |||||||||||||||||||||
| 14 | from the previous year. Most of those preventable deaths | |||||||||||||||||||||
| 15 | involved opioids. | |||||||||||||||||||||
| 16 | (2) A significant reason for the increase in deaths is | |||||||||||||||||||||
| 17 | a poisoned drug supply, with illicit fentanyl killing | |||||||||||||||||||||
| 18 | people using street-bought substances. With the increasing | |||||||||||||||||||||
| 19 | use of potent fentanyl in the illicit substance supply in | |||||||||||||||||||||
| 20 | Illinois, more lives will continue to be lost. | |||||||||||||||||||||
| 21 | (3) Nearly all witnessed opioid overdoses are | |||||||||||||||||||||
| 22 | reversible with the provision of oxygen, naloxone, and | |||||||||||||||||||||
| 23 | other emergency care. However, many people use drugs alone | |||||||||||||||||||||
| |||||||
| |||||||
| 1 | or use them with people who do not have naloxone and are | ||||||
| 2 | not trained in overdose response. | ||||||
| 3 | (4) Overdose prevention sites can save lives. Overdose | ||||||
| 4 | prevention sites provide individuals with a safe, hygienic | ||||||
| 5 | space to consume pre-obtained drugs and access to other | ||||||
| 6 | harm reduction, treatment, recovery, and ancillary support | ||||||
| 7 | services. | ||||||
| 8 | (5) The goals of overdose prevention sites are: | ||||||
| 9 | (A) Saving lives by quickly providing emergency | ||||||
| 10 | care to persons experiencing an overdose. | ||||||
| 11 | (B) Reducing the spread of infectious diseases, | ||||||
| 12 | such as HIV and hepatitis. | ||||||
| 13 | (C) Reducing public injection of substances and | ||||||
| 14 | discarded syringes in surrounding areas. | ||||||
| 15 | (D) Linking those with substance use disorders to | ||||||
| 16 | behavioral and physical health supports. | ||||||
| 17 | (b) Definitions. As used in this Section: | ||||||
| 18 | "Entity" means (i) any community-based organization that | ||||||
| 19 | provides educational, health, harm reduction, housing, or | ||||||
| 20 | social services and (ii) any hospital, medical clinic or | ||||||
| 21 | office, health center, community-based mental health center, | ||||||
| 22 | or other similar entity that provides medical care. | ||||||
| 23 | "Harm reduction" refers to a philosophical framework and | ||||||
| 24 | set of strategies designed to reduce harm and promote dignity | ||||||
| 25 | and well-being among persons and communities who engage in | ||||||
| 26 | substance use. | ||||||
| |||||||
| |||||||
| 1 | "Overdose prevention sites" means hygienic locations where | ||||||
| 2 | individuals may safely consume pre-obtained substances. | ||||||
| 3 | "Participant" means an individual who seeks to utilize, | ||||||
| 4 | utilizes, or has utilized services provided at an overdose | ||||||
| 5 | prevention site established in accordance with this Section. | ||||||
| 6 | (c) Overdose prevention sites; licensure. The Department | ||||||
| 7 | shall establish a new intervention license category entitled | ||||||
| 8 | "OPS Harm Reduction Services" for entities seeking to operate | ||||||
| 9 | an overdose prevention site to provide harm reduction services | ||||||
| 10 | to persons who use controlled substances. Within 12 months | ||||||
| 11 | after the effective date of this amendatory Act of the 103rd | ||||||
| 12 | General Assembly, the Department shall establish standards for | ||||||
| 13 | entities to become licensed under the OPS Harm Reduction | ||||||
| 14 | Services category and shall create an application process for | ||||||
| 15 | entities to apply for and obtain an OPS Harm Reduction | ||||||
| 16 | Services license. These standards shall be informed by harm | ||||||
| 17 | reduction principles and developed with the input of persons | ||||||
| 18 | who use or formerly used controlled substances. | ||||||
| 19 | Notwithstanding any other law, ordinance, or regulation, | ||||||
| 20 | any entity licensed as an OPS Harm Reduction Services provider | ||||||
| 21 | may operate an overdose prevention site as authorized by the | ||||||
| 22 | Department. | ||||||
| 23 | (d) The Department shall make a determination as to | ||||||
| 24 | whether to approve an entity's application for an OPS Harm | ||||||
| 25 | Reduction Services license within 4 weeks after the date upon | ||||||
| 26 | which the entity submitted its application to the Department. | ||||||
| |||||||
| |||||||
| 1 | No OPS Harm Reduction Services license shall be granted to an | ||||||
| 2 | entity seeking to operate an overdose prevention site in a | ||||||
| 3 | municipality with a population of less than 2,500,000 | ||||||
| 4 | inhabitants until such entity is first licensed to operate an | ||||||
| 5 | overdose prevention site in a municipality with a population | ||||||
| 6 | of 2,500,000 or more inhabitants. Each initial license shall | ||||||
| 7 | be valid for 2 years and, after the initial 2-year license | ||||||
| 8 | period, may be renewed for a specified period as determined by | ||||||
| 9 | the Department. | ||||||
| 10 | An entity may apply for an OPS Harm Reduction Services | ||||||
| 11 | license at any time, regardless of previous applications. | ||||||
| 12 | The Department shall help educate local communities and | ||||||
| 13 | public and private entities, such as public safety | ||||||
| 14 | organizations, social service groups, school districts, faith | ||||||
| 15 | communities, and businesses, about overdose prevention sites | ||||||
| 16 | and the evidence regarding the benefits of overdose prevention | ||||||
| 17 | sites. | ||||||
| 18 | (e) Overdose prevention site features. An entity approved | ||||||
| 19 | to operate an overdose prevention site shall, at a minimum: | ||||||
| 20 | (1) provide a hygienic space where participants may | ||||||
| 21 | consume pre-obtained substances; | ||||||
| 22 | (2) maintain a supply of naloxone and oxygen on-site, | ||||||
| 23 | together with the necessary equipment to administer | ||||||
| 24 | naloxone and oxygen; | ||||||
| 25 | (3) monitor participants for potential overdose; | ||||||
| 26 | (4) employ staff trained to administer first aid to | ||||||
| |||||||
| |||||||
| 1 | participants who are experiencing an overdose; | ||||||
| 2 | (5) provide sterile injection or other substance use | ||||||
| 3 | supplies, collect used hypodermic needles and syringes, | ||||||
| 4 | and provide secure hypodermic needle and syringe disposal | ||||||
| 5 | services in compliance with the Overdose Prevention and | ||||||
| 6 | Harm Reduction Act and any applicable rules adopted by the | ||||||
| 7 | Department of Public Health; | ||||||
| 8 | (6) provide safer smoking and safer snorting kits; | ||||||
| 9 | (7) provide naloxone; | ||||||
| 10 | (8) encourage drug checking or the use of fentanyl | ||||||
| 11 | test strips; | ||||||
| 12 | (9) provide education on safe consumption practices, | ||||||
| 13 | the proper disposal of hypodermic needles and syringes, | ||||||
| 14 | and overdose prevention; | ||||||
| 15 | (10) provide referrals to substance use disorder and | ||||||
| 16 | mental health treatment, medication-assisted treatment or | ||||||
| 17 | recovery, and other services which address social | ||||||
| 18 | determinants of health; | ||||||
| 19 | (11) offer a quiet and comfortable space for | ||||||
| 20 | participants to stay safely sheltered and supervised after | ||||||
| 21 | consuming substances; and | ||||||
| 22 | (12) train staff members and volunteers to deliver | ||||||
| 23 | services offered at the overdose prevention site, and | ||||||
| 24 | maintain an adequate staff of health care professionals or | ||||||
| 25 | other trained staff or volunteers. | ||||||
| 26 | (f) Reporting. An entity operating an overdose prevention | ||||||
| |||||||
| |||||||
| 1 | site in accordance with this Section shall, within the time | ||||||
| 2 | frame specified by the Department, submit a report to the | ||||||
| 3 | Department that shall include: | ||||||
| 4 | (1) the number of participants who have received or | ||||||
| 5 | are receiving services at the overdose prevention site; | ||||||
| 6 | (2) aggregate information regarding the | ||||||
| 7 | characteristics of those participants reported under | ||||||
| 8 | paragraph (1); | ||||||
| 9 | (3) the number of hypodermic needles, syringes, and | ||||||
| 10 | harm reduction supplies distributed for use on-site; | ||||||
| 11 | (4) the number of overdoses experienced and the number | ||||||
| 12 | of overdoses reversed on-site; | ||||||
| 13 | (5) the number of participants directly and formally | ||||||
| 14 | referred to other services and the type of services. | ||||||
| 15 | (g) Immunity provided. Notwithstanding the Illinois | ||||||
| 16 | Controlled Substances Act, the Drug Paraphernalia Control Act, | ||||||
| 17 | or any other provision of law to the contrary, the following | ||||||
| 18 | persons shall not be arrested, charged, or prosecuted for any | ||||||
| 19 | criminal offense, or be subject to any civil or administrative | ||||||
| 20 | penalty, including seizure or forfeiture of assets or real | ||||||
| 21 | property or disciplinary action by a professional licensing | ||||||
| 22 | board, or be denied any right or privilege solely for | ||||||
| 23 | participation or involvement at an overdose prevention site | ||||||
| 24 | approved by the Department under this Act: | ||||||
| 25 | (1) any individual who seeks to utilize, utilizes, or | ||||||
| 26 | has utilized services provided at an overdose prevention | ||||||
| |||||||
| |||||||
| 1 | site established in accordance with this Section; | ||||||
| 2 | (2) a staff member or administrator of an overdose | ||||||
| 3 | prevention site, including a healthcare professional, | ||||||
| 4 | manager, employee, or volunteer; and | ||||||
| 5 | (3) an individual who owns real property at which an | ||||||
| 6 | overdose prevention site is located or operates. | ||||||
| 7 | (h) Home rule preemption. A home rule unit may not | ||||||
| 8 | prohibit the establishment or operation of an overdose | ||||||
| 9 | prevention site as provided in this Section. This Section is a | ||||||
| 10 | denial and limitation of home rule powers and functions under | ||||||
| 11 | subsection (g) of Section 6 of Article VII of the Illinois | ||||||
| 12 | Constitution.
| ||||||
| 13 | (20 ILCS 301/15-10)
| ||||||
| 14 | Sec. 15-10. Licensure categories and services. No person, | ||||||
| 15 | entity, or program may provide the
services or conduct the | ||||||
| 16 | activities described in this Section without first
obtaining a | ||||||
| 17 | license therefor from the Department, unless otherwise | ||||||
| 18 | exempted under this Act. The Department shall, by
rule, | ||||||
| 19 | provide requirements for each of the following types of | ||||||
| 20 | licenses and categories of service: | ||||||
| 21 | (a) Treatment: Categories of service authorized by a | ||||||
| 22 | treatment license are Early Intervention, Outpatient, | ||||||
| 23 | Intensive Outpatient/Partial Hospitalization, Subacute | ||||||
| 24 | Residential/Inpatient, and Withdrawal Management. | ||||||
| 25 | Medication assisted treatment that includes methadone used | ||||||
| |||||||
| |||||||
| 1 | for an opioid use disorder can be licensed as an adjunct to | ||||||
| 2 | any of the treatment levels of care specified in this | ||||||
| 3 | Section. | ||||||
| 4 | (b) Intervention: Categories of service authorized by | ||||||
| 5 | an intervention license are DUI Evaluation, DUI Risk | ||||||
| 6 | Education, Designated Program, OPS Harm Reduction | ||||||
| 7 | Services, and Recovery Homes for persons in any stage of | ||||||
| 8 | recovery from a substance use disorder.
| ||||||
| 9 | The Department may, under procedures established by rule | ||||||
| 10 | and upon a showing
of good cause for such, exempt off-site | ||||||
| 11 | services from having to obtain a
separate license for services | ||||||
| 12 | conducted away from the provider's licensed location.
| ||||||
| 13 | (Source: P.A. 100-759, eff. 1-1-19.)
| ||||||